University Hospitals Bristol
Welcome,         Profile    Billing    Logout  
 1 Trial 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Johnson, Tom
PEPSii, NCT04701385: Plaque Erosion Prospective Study ii

Completed
N/A
33
Europe
Optical Coherence Tomography (OCT)
Norfolk and Norwich University Hospitals NHS Foundation Trust
Atheroma; Myocardial
01/22
01/23
NCT04859985: The SELUTION DeNovo Study

Active, not recruiting
N/A
3326
Europe, RoW
SELUTION SLR, DES
M.A. Med Alliance S.A.
Coronary Artery Disease
08/25
07/30
OPTIMAL, NCT04111770: The Randomized Controlled Trial

Active, not recruiting
N/A
807
Europe
IVUS guided Percutaneous Coronary Intervention, QCA guided Percutaneous Coronary Intervention
ECRI bv, Philips Healthcare, Boston Scientific Corporation
Left Main Coronary Artery Stenosis
07/25
07/25
Protheroe, Rachel
AMADEUS, NCT04173533 / 2018-001012-30: Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

Active, not recruiting
3
326
Europe
Oral azacitidine, CC-486, Matched placebo, Oral azacitidine matched placebo
University of Birmingham
Acute Myeloid Leukemia, Myelodysplasia
04/25
04/25
COSI, NCT04217278: A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Active, not recruiting
2/3
333
Europe
Vyxeos, CPX-351, Fludarabine, Fludara, Busulphan, Busulfan, Bulsivex, Thiotepa, Tepadina, Cytarabine, Ara-C, Cytosine arabinoside
University of Birmingham, Jazz Pharmaceuticals, IMPACT (funded by NHS Blood & Transplant, Anthony Nolan and Leukaemia UK), Adienne SA
Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome
03/25
03/25
ACHIEVE, NCT05358808: - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)

Recruiting
2
53
Europe
TCB008, CD3+ T cells expressing the γ-chain variable region 9 δ-chain variable region 2 (Vγ9Vδ2) T cell receptor (TCR)
TC Biopharm
Acute Myeloid Leukemia, Myelodysplastic Syndromes
12/25
12/25
Ramanan, A V
NCT03816397: Adalimumab in JIA-associated Uveitis Stopping Trial

Active, not recruiting
4
118
Europe, US, RoW
Adalimumab, HUMIRA, Placebo
Nisha Acharya, Children's Hospital of Philadelphia, Children's Hospital Medical Center, Cincinnati, Children's Mercy Hospital Kansas City, National Eye Institute (NEI), Great Ormond Street Hospital for Children NHS Foundation Trust, University Hospitals Bristol and Weston NHS Foundation Trust, Alder Hey Children's NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, Sheffield Children's NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Royal Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Vanderbilt University Medical Center, University of California, Davis, University of Texas at Austin, University of Miami, University Hospitals, Leicester, University of Utah, Colorado Retina Associates, Manchester University NHS Foundation Trust
Uveitis, JIA
04/25
07/25
Dick, Andrew
NCT03816397: Adalimumab in JIA-associated Uveitis Stopping Trial

Active, not recruiting
4
118
Europe, US, RoW
Adalimumab, HUMIRA, Placebo
Nisha Acharya, Children's Hospital of Philadelphia, Children's Hospital Medical Center, Cincinnati, Children's Mercy Hospital Kansas City, National Eye Institute (NEI), Great Ormond Street Hospital for Children NHS Foundation Trust, University Hospitals Bristol and Weston NHS Foundation Trust, Alder Hey Children's NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, Sheffield Children's NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Royal Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Vanderbilt University Medical Center, University of California, Davis, University of Texas at Austin, University of Miami, University Hospitals, Leicester, University of Utah, Colorado Retina Associates, Manchester University NHS Foundation Trust
Uveitis, JIA
04/25
07/25
Burren, Christine
PROPEL, NCT04035811: Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

Recruiting
N/A
250
Europe, Canada, US, RoW
QED Therapeutics, Inc.
Achondroplasia
06/26
06/26
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia

Recruiting
N/A
1343
Europe, RoW
Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd
X-Linked Hypophosphatemia
02/29
07/29
Abdelaal, Eltigani
NCT04859985: The SELUTION DeNovo Study

Active, not recruiting
N/A
3326
Europe, RoW
SELUTION SLR, DES
M.A. Med Alliance S.A.
Coronary Artery Disease
08/25
07/30

Download Options